Pfizer Share Price: What to Expect from Q1 Results
In this article we find out what we can expect from the upcoming Pfizer results, how they could affect the Pfizer share price, as well as how to trade the earnings.
Pfizer share price: what to expect from Q1 2021 results
When does Pfizer release earnings?
The Pfizer earnings release date is scheduled for the 4th of May 2021. The scheduled results will cover the group’s Q1 FY21 earnings (January to March 2021)
Pfizer results preview: what does the street expect?
Pfizer, the research-based global biopharmaceutical company, is expected to see low double digit revenue growth for Q1 2021 when compared to the prior year’s comparative period (Q1 2020), although earnings per share for the period are expected to be relatively flat against the comparative due to an increased cost base.
The average estimates for the upcoming results are as follows: • Revenue for the quarter expected at $13.6 billion • Earnings per share for the quarter expected at $0.78.
How to trade Pfizer Q1 results
The below two graphics provide traders with both a retail short-term view on the stock, as well as an institutional longer term view on the Pfizer share price, as to how market participants are positioned ahead of the Q1 earnings release.
A Refinitiv poll of 22 analysts maintains a long-term average rating of ‘hold’ for Pfizer (as of 3rd of May 2021), with two of these analysts recommending a strong buy, fice recommending a buy, 15 hold, zero sell and zero strong sell recommendations on the stock.
From a retail trader perspective (as of 3rd of May 2021), 99% of IG clients with open positions on Pfizer expect the share price to rise over the near term, while 1% of IG clients with open positions expect the Pfizer price to fall.
Pfizer share price: technical analysis
The Pfizer share price is currently testing resistance of the 33.40 to 39.30 range within which it currently trades.
For a bullish trading scenario, traders will want to see a confirmed (with a daily close) break of the 39.30 level, before targeting a move to the near term high at 42.90. In this scenario, a close below the dotted trendline may be used as a stop-loss consideration.
For a bearish trading scenario, a close below the dotted trendline support could indicate that the price is now looking to return to range support at 33.40. In this scenario, 33.40 becomes the downside target, while a close above range resistance at 39.30 could be used as a stop-loss consideration for the trade.
In summary:
• Pfizer Q1 FY21 results are scheduled for release on the 4th of May
• Group revenue for the quarter is expected to be realized at $13.6bn
• Earnings per share for the quarter are expected to be realized at $0.78
• The majority of IG clients with open positions on Pfizer expect the price to rise in the near term
• A technical analysis view on the Pfizer share price shows a short to medium term rangebound price environment.
Related articles
Live prices on most popular markets
- Equities
- Indices
- Forex
- Commodities
Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.
